FLURBIPROFEN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for flurbiprofen sodium and what is the scope of freedom to operate?
Flurbiprofen sodium
is the generic ingredient in two branded drugs marketed by Bausch And Lomb and Allergan, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for flurbiprofen sodium. Four suppliers are listed for this compound.
Summary for FLURBIPROFEN SODIUM
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Clinical Trials: | 2 |
Patent Applications: | 211 |
What excipients (inactive ingredients) are in FLURBIPROFEN SODIUM? | FLURBIPROFEN SODIUM excipients list |
DailyMed Link: | FLURBIPROFEN SODIUM at DailyMed |
Recent Clinical Trials for FLURBIPROFEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Guangxi Medical University | Phase 4 |
Pharmacology for FLURBIPROFEN SODIUM
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for FLURBIPROFEN SODIUM
US Patents and Regulatory Information for FLURBIPROFEN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | OCUFEN | flurbiprofen sodium | SOLUTION/DROPS;OPHTHALMIC | 019404-001 | Dec 31, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb | FLURBIPROFEN SODIUM | flurbiprofen sodium | SOLUTION/DROPS;OPHTHALMIC | 074447-001 | Jan 4, 1995 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLURBIPROFEN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | OCUFEN | flurbiprofen sodium | SOLUTION/DROPS;OPHTHALMIC | 019404-001 | Dec 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OCUFEN | flurbiprofen sodium | SOLUTION/DROPS;OPHTHALMIC | 019404-001 | Dec 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.